AU3361693A - Use of 5-HT4 receptor antagonists as medicaments for treating migraine - Google Patents

Use of 5-HT4 receptor antagonists as medicaments for treating migraine

Info

Publication number
AU3361693A
AU3361693A AU33616/93A AU3361693A AU3361693A AU 3361693 A AU3361693 A AU 3361693A AU 33616/93 A AU33616/93 A AU 33616/93A AU 3361693 A AU3361693 A AU 3361693A AU 3361693 A AU3361693 A AU 3361693A
Authority
AU
Australia
Prior art keywords
medicaments
receptor antagonists
treating migraine
migraine
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33616/93A
Inventor
Alberto Julio Kaumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929201484A external-priority patent/GB9201484D0/en
Priority claimed from GB929219318A external-priority patent/GB9219318D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU3361693A publication Critical patent/AU3361693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU33616/93A 1992-01-23 1993-01-20 Use of 5-HT4 receptor antagonists as medicaments for treating migraine Abandoned AU3361693A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9201484 1992-01-23
GB929201484A GB9201484D0 (en) 1992-01-23 1992-01-23 Medicaments
GB9219318 1992-09-11
GB929219318A GB9219318D0 (en) 1992-09-11 1992-09-11 Medicaments

Publications (1)

Publication Number Publication Date
AU3361693A true AU3361693A (en) 1993-09-01

Family

ID=26300202

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33616/93A Abandoned AU3361693A (en) 1992-01-23 1993-01-20 Use of 5-HT4 receptor antagonists as medicaments for treating migraine

Country Status (2)

Country Link
AU (1) AU3361693A (en)
WO (1) WO1993014745A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
AU4081393A (en) * 1992-05-23 1993-12-30 Smithkline Beecham Plc Medicaments for the treatment of anxiety
JPH08502283A (en) * 1992-10-16 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5-HT 4) Fused ring system N-alkylpiperidinyl-4-methylcarboxylic acid ester / amide for receptor antagonist
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (en) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivatives of indazole-3-carboxamide and -3-carboxylic acid
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
FR2674855B1 (en) * 1991-04-03 1994-01-14 Synthelabo PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
WO1993014745A1 (en) 1993-08-05

Similar Documents

Publication Publication Date Title
IL117841A0 (en) Process for the preparating of respirable particels
AU4265496A (en) Perhydroisoindole derivatives as antagonists of substance p
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL125404A0 (en) 4-amino-pyrimidine derivatives medicaments containing these compounds their use and process for their production
AU5194496A (en) 5-HT4 receptor antagonists
ZA9510431B (en) Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
AU4873193A (en) Use of substituted benzimidazoles
PL326083A1 (en) Novel pyrimidin derivatives as antagonists of 5ht 2c receptor
AU4247293A (en) Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
AU4261293A (en) 1-piperazineacetic derivatives as fibrinogen receptor antagonists
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
AU8534291A (en) Renal-selective angiotensin ii antagonists for treatment of hypertension
ZA937505B (en) Imidazopyridine derivatives as 5-HT4 receptor antagonists
HU9503089D0 (en) Use of indole derivatives as 5ht1 antagonists
AU4163793A (en) Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
AU3361693A (en) Use of 5-HT4 receptor antagonists as medicaments for treating migraine
PL330708A1 (en) Derivatives of indolydine useful as antagonists of 5-ht-2c receptor
HUP0000233A3 (en) Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency
AU2000792A (en) Knee-cap for treatment of injured joint
AU7059296A (en) NK-1 receptor antagonists for the treatment of cancer
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
AU5627194A (en) New use of 5-ht3 receptor antagonists
HUP0003803A3 (en) Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
HUP9600333A2 (en) Azole derivatives as adhesive receptor antagonists, pharmaceutical compositions containing the same and process for their preparation